Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hayandra Peduli Foundation is an Indonesian biotechnology organization and foundation dedicated to regenerative medicine and community health. Operating alongside Hayandra Lab and Klinik Hayandra, the foundation specializes in the clinical application of autologous stem cells, stromal vascular fraction (SVF), and immune cell therapies such as Natural Killer (NK) cells. The organization is well-known for its research into degenerative diseases and its philanthropic efforts, particularly providing free corrective surgeries for children with cleft lip and palate. Hayandra is a pioneer in the Indonesian biotech sector, maintaining high-standard cell processing facilities to translate laboratory research into accessible therapeutic interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hayandra Peduli Foundation.